Eloxx Pharmaceuticals Seeks to Raise $50 Million in Public Offering

Eloxx Pharmaceuticals, Inc. (Nasdaq:ELOX) on 4/25/18 announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price to the public of $9.75 per share. The gross proceeds to Eloxx from the offering are expected to be approximately $50 million, before deducting the underwriting discounts and commissions and offering expenses.